hat
Zouti te kapab pèmèt ki pisan tretman pèsonalize ki pwòp sistèm iminitè pasyan premye 'al atake makè byolojik sou timè
eng
Breakthrough could allow potent personalised treatments which prime patients’ own immune systems to attack biological markers on tumours